What does MEMO MEDICAL do?

MEMO MEDICAL is a call centre in Zele. Non-profit, started on 27 October 2015, 2 establishments.

What is the address of MEMO MEDICAL?

The registered office of MEMO MEDICAL is located at Lokerenbaan 70, 9240 Zele.

Is MEMO MEDICAL still active?

Yes. According to the CBE (29 October 2026) MEMO MEDICAL is active, legal situation “Normale toestand”, started on 27 October 2015.

Is MEMO MEDICAL registered on Peppol?

Yes, MEMO MEDICAL is registered on the Peppol network with ID 0208:0641922739.

What is the enterprise number of MEMO MEDICAL?

The enterprise number of MEMO MEDICAL is BE0641922739.

When was MEMO MEDICAL founded?

MEMO MEDICAL was founded on 27 October 2015.

Who are the directors of MEMO MEDICAL?

According to the 2025 annual accounts, the directors of MEMO MEDICAL are: Feynman, Vincent De Decker, MEMO.

Is MEMO MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 October 2015; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account; 2 establishments in the CBE.

How much profit did MEMO MEDICAL make in 2025?

MEMO MEDICAL posted a profit after taxes of € 6,459 in financial year 2025.

What is the revenue of MEMO MEDICAL?

As a small company, MEMO MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 241,016.

How much does an employee at MEMO MEDICAL earn?

The average wage cost per full-time employee at MEMO MEDICAL was € 34,500 in 2025: staff costs of € 214,138 for 6.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does MEMO MEDICAL have?

According to the 2025 annual accounts, MEMO MEDICAL has 6.2 full-time equivalents (FTE).

MEMO MEDICAL (Non-profit) - Zele - BE0641922739

Dossier MEMO MEDICAL, printed on 29 October 2026 from databakkes.be/en/0641922739/memo-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Shrinking team NBB

FTE fell two years in a row, from 9.5 to 6.2.

Financials

Financial year 2025

MEMO MEDICAL from Zele, company number BE0641922739, closed financial year 2025 with a result of € 6,459 after tax. For that financial year MEMO MEDICAL recorded a gross margin of € 241,016 and equity of € -51,471. Compared with financial year 2024, the result moved from € 1,662 to € 6,459. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Caution

€ -51,471

▲ € 6,459 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 6,459

▲ 289% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 11,792

▲ 4% vs 2024

Cash and bank balances on the last day of the fiscal year.

People and assets in 2025

Full-time equivalents

6.2

▼ 0.7 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 214,138

▼ 36% vs 2024

€ 34,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

€ 21,047

▼ 7% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 16,880

▼ 43% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 36,546

▼ 38% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 481,673 Gross margin 2022: € 481,673 First fiscal year in the series	€ 490,329 Gross margin 2023: € 490,329 ▲ 2% vs 2022 (€ 481,673) Favourable step	€ 358,608 Gross margin 2024: € 358,608 ▼ 27% vs 2023 (€ 490,329) Unfavourable step	€ 241,016 Gross margin 2025: € 241,016 ▼ 33% vs 2024 (€ 358,608) Unfavourable step	▼ 33%
Profit after taxes	€ -13,015 Profit after taxes 2022: € -13,015 First fiscal year in the series	€ -18,516 Profit after taxes 2023: € -18,516 ▼ € 5,501 vs 2022 (€ -13,015) Unfavourable step	€ 1,662 Profit after taxes 2024: € 1,662 ▲ € 20,178 vs 2023 (€ -18,516) Favourable step	€ 6,459 Profit after taxes 2025: € 6,459 ▲ 289% vs 2024 (€ 1,662) Favourable step	▲ 289%
Equity	€ -41,076 Equity 2022: € -41,076 First fiscal year in the series	€ -59,592 Equity 2023: € -59,592 ▼ € 18,516 vs 2022 (€ -41,076) Unfavourable step	€ -57,930 Equity 2024: € -57,930 ▲ € 1,662 vs 2023 (€ -59,592) Favourable step	€ -51,471 Equity 2025: € -51,471 ▲ € 6,459 vs 2024 (€ -57,930) Favourable step	▲ € 6,459
Total debts	€ 382,976 Total debts 2022: € 382,976 First fiscal year in the series	€ 672,786 Total debts 2023: € 672,786 ▲ 76% vs 2022 (€ 382,976) Unfavourable step	€ 833,167 Total debts 2024: € 833,167 ▲ 24% vs 2023 (€ 672,786) Unfavourable step	€ 920,822 Total debts 2025: € 920,822 ▲ 11% vs 2024 (€ 833,167) Unfavourable step	▲ 11%
Cash	€ 21,822 Cash 2022: € 21,822 First fiscal year in the series	€ 29,971 Cash 2023: € 29,971 ▲ 37% vs 2022 (€ 21,822) Favourable step	€ 11,345 Cash 2024: € 11,345 ▼ 62% vs 2023 (€ 29,971) Unfavourable step	€ 11,792 Cash 2025: € 11,792 ▲ 4% vs 2024 (€ 11,345) Favourable step	▲ 4%
Retained profit	€ -41,076 Retained profit 2022: € -41,076 First fiscal year in the series	€ -59,592 Retained profit 2023: € -59,592 ▼ € 18,516 vs 2022 (€ -41,076) Unfavourable step	€ -57,930 Retained profit 2024: € -57,930 ▲ € 1,662 vs 2023 (€ -59,592) Favourable step	€ -51,471 Retained profit 2025: € -51,471 ▲ € 6,459 vs 2024 (€ -57,930) Favourable step	▲ € 6,459
Bank debt	€ 44,104 Bank debt 2022: € 44,104 First fiscal year in the series	€ 33,284 Bank debt 2023: € 33,284 ▼ 25% vs 2022 (€ 44,104) Favourable step	€ 22,726 Bank debt 2024: € 22,726 ▼ 32% vs 2023 (€ 33,284) Favourable step	€ 21,047 Bank debt 2025: € 21,047 ▼ 7% vs 2024 (€ 22,726) Favourable step	▼ 7%
Balance sheet total	€ 341,900 Balance sheet total 2022: € 341,900 First fiscal year in the series	€ 613,193 Balance sheet total 2023: € 613,193 ▲ 79% vs 2022 (€ 341,900) Unchanged	€ 775,237 Balance sheet total 2024: € 775,237 ▲ 26% vs 2023 (€ 613,193) Unchanged	€ 869,351 Balance sheet total 2025: € 869,351 ▲ 12% vs 2024 (€ 775,237) Unchanged	▲ 12%
Employees (FTE)	-	9.5 Employees (FTE) 2023: 9.5 First fiscal year in the series	6.9 Employees (FTE) 2024: 6.9 ▼ 2.6 vs 2023 (9.5) Unchanged	6.2 Employees (FTE) 2025: 6.2 ▼ 0.7 vs 2024 (6.9) Unchanged	▼ 0.7

Key figures of MEMO MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEMO MEDICAL?

What happened at MEMO MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 6,459 (▲ 289% vs 2024). Source: NBB ↗
2026 Vincent De Decker became a director. NBB
Jan 1, 2024 New establishment in Aalst. KBO
2020 Feynman became a director. NBB
Jan 5, 2016 New establishment in Zele. KBO
Oct 27, 2015 Start of the company according to the CBE. KBO
2015 MEMO became a director. NBB

In short

From € 13,015 loss in 2022 to € 6,459 profit in 2025.

Paid € 68 in corporate taxes since 2022.

Best year ever: 2025, with € 6,459 profit.

On average € 38,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Feynman Vincent De Decker MEMO

OFFITEL MEDICAL

PAPILIO

MEMO MEDICAL

DECKERLAND

Behind MEMO MEDICAL are Feynman, Vincent De Decker and MEMO. Feynman is also behind OFFITEL MEDICAL and PAPILIO. Vincent De Decker is also behind DECKERLAND, OFFITEL MEDICAL and PAPILIO.

Directors

According to the 2025 annual accounts

Feynman

Director · represented by Michael De Decker

Also active at: OFFITEL MEDICAL, PAPILIO

since 2020

Vincent De Decker

Director

Also active at: DECKERLAND, OFFITEL MEDICAL, PAPILIO

since 2026

MEMO

Director · represented by Christine Vastenavondt

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Lokerenbaan 70

9240 Zele

2.356.233.433

Esplanadeplein 8a

9300 Aalst

Active since 1 January 2024

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

MEMO same network

€ 2.2 million gross margin · 2025

HOLDING MEMO

€ 109,638 gross margin · 2025

PAPILIO same network

€ 208,672 gross margin · 2025

FEYNMAN same network

€ 91,810 gross margin · 2025

COPAINS

€ -47,110 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0641.922.739

VAT number

BE 0641.922.739

Registered office

Lokerenbaan 70, 9240 Zele

Names & denominations

MEMO MEDICAL

Enterprise type

Rechtspersoon

Legal form

Non-profit association

Legal situation

Normale toestand

Start date

27 October 2015

Peppol

Active · Active since 9 Apr 2026

Activities · NACE

Activiteiten van callcenters

Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

MEMO MEDICAL

Warning lights

Financials

What happened to MEMO MEDICAL?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions